FDA Ducks ViroPharma Suit Over Generics Guidelines

Law360, New York (April 15, 2011, 9:43 PM EDT) -- The U.S. Food and Drug Administration dodged a suit Friday brought by ViroPharma Inc. over its guidelines for testing whether generic drugs are equivalent to brand names.

Judge Ellen S. Huvelle of the U.S. District Court for the District of Columbia ruled that Exton, Pa.-based ViroPharma lacked standing to pursue its suit, which it filed to try to make it harder for generic makers to compete with its gastrointestinal antibiotic Vancocin.

The company had argued that the FDA illegally changed the rules in 2008 when it...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

VIROPHARMA INCORPORATED v. HAMBURG et al


Case Number

1:10-cv-01529

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Ellen S. Huvelle

Date Filed

September 10, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.